Bigora Sian

CIK 00017993651 companyHANOVER, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001799365

Recent Transactions

29 trades

Exercise/Conversion
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2024-07-10+644→ 22,103 total
Tax Payment
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2024-07-10$1.71/sh−225→ 21,878 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2024-06-28+2,425→ 27,153 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2024-06-28+404→ 27,961 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2024-06-28+404→ 27,557 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2024-06-28+3,233→ 24,728 total
Tax Payment
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2024-04-05$2.79/sh−368→ 21,459 total
Exercise/Conversion
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2024-04-05+1,675→ 21,827 total
Exercise/Conversion
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2024-01-01+1,675→ 21,826 total
Exercise/Conversion
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2024-01-01−1,675→ 22,139 total
Tax Payment
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2024-01-01$2.79/sh−368→ 21,458 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2023-01-01+75,907→ 431,985 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2023-01-01+48,490→ 480,475 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2022-12-31+13,851→ 356,073 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2022-09-30+13,850→ 342,227 total
Exercise/Conversion
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2022-08-05+7,601→ 403,019 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2022-06-30+25,611→ 328,377 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2022-04-01+247,841→ 302,766 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2022-03-31+10,715→ 37,781 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-12-31+6,722→ 6,722 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-12-31+6,722→ 22,780 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-11-01+4,286→ 27,066 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-09-30+6,024→ 16,058 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-09-30+6,024→ 6,024 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Common Stock
2021-08-05+7,601→ 395,418 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-07-08+1,907→ 10,034 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-07-08+12,858→ 12,858 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-07-08+8,572→ 8,572 total
Award
Processa Pharmaceuticals, Inc.$PCSA
Restricted Stock Units
2021-06-08+8,127→ 8,127 total

Companies

Processa Pharmaceuticals, Inc.
Chief Development Officer
$PCSA

Recent Filings

Address

C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106

HANOVER, MD, 20176

View on SEC.gov